These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 18603070

  • 1. A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targeted.
    Nagendran J, Gurtu V, Fu DZ, Dyck JR, Haromy A, Ross DB, Rebeyka IM, Michelakis ED.
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):168-78, 178.e1-3. PubMed ID: 18603070
    [Abstract] [Full Text] [Related]

  • 2. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility.
    Nagendran J, Archer SL, Soliman D, Gurtu V, Moudgil R, Haromy A, St Aubin C, Webster L, Rebeyka IM, Ross DB, Light PE, Dyck JR, Michelakis ED.
    Circulation; 2007 Jul 17; 116(3):238-48. PubMed ID: 17606845
    [Abstract] [Full Text] [Related]

  • 3. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
    Chiang CS, Huang CH, Chieng H, Chang YT, Chang D, Chen JJ, Chen YC, Chen YH, Shin HS, Campbell KP, Chen CC.
    Circ Res; 2009 Feb 27; 104(4):522-30. PubMed ID: 19122177
    [Abstract] [Full Text] [Related]

  • 4. Normal right ventricular three-dimensional architecture, as assessed with diffusion tensor magnetic resonance imaging, is preserved during experimentally induced right ventricular hypertrophy.
    Nielsen E, Smerup M, Agger P, Frandsen J, Ringgard S, Pedersen M, Vestergaard P, Nyengaard JR, Andersen JB, Lunkenheimer PP, Anderson RH, Hjortdal V.
    Anat Rec (Hoboken); 2009 May 27; 292(5):640-51. PubMed ID: 19306437
    [Abstract] [Full Text] [Related]

  • 5. Prostacyclin therapy increases right ventricular capillarisation in a model for flow-associated pulmonary hypertension.
    van Albada ME, Berger RM, Niggebrugge M, van Veghel R, Cromme-Dijkhuis AH, Schoemaker RG.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):107-16. PubMed ID: 16978602
    [Abstract] [Full Text] [Related]

  • 6. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S, Ellinghaus P, Janssen W, Kramer F, Lustig K, Milting H, Kast R, Klein M.
    Cardiovasc Res; 2009 Apr 01; 82(1):30-9. PubMed ID: 19131365
    [Abstract] [Full Text] [Related]

  • 7. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Letavernier E, Perez J, Bellocq A, Mesnard L, de Castro Keller A, Haymann JP, Baud L.
    Circ Res; 2008 Mar 28; 102(6):720-8. PubMed ID: 18258859
    [Abstract] [Full Text] [Related]

  • 8. Bone-marrow-derived CXCR4-positive tissue-committed stem cell recruitment in human right ventricular remodeling.
    Castellani C, Padalino M, China P, Fedrigo M, Frescura C, Milanesi O, Stellin G, Thiene G, Angelini A.
    Hum Pathol; 2010 Nov 28; 41(11):1566-76. PubMed ID: 20621330
    [Abstract] [Full Text] [Related]

  • 9. Upregulation of embryonic transcription factors in right ventricular hypertrophy.
    Bär H, Kreuzer J, Cojoc A, Jahn L.
    Basic Res Cardiol; 2003 Sep 28; 98(5):285-94. PubMed ID: 12955401
    [Abstract] [Full Text] [Related]

  • 10. The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes.
    Saygili E, Rana OR, Meyer C, Gemein C, Andrzejewski MG, Ludwig A, Weber C, Schotten U, Krüttgen A, Weis J, Schwinger RH, Mischke K, Rassaf T, Kelm M, Schauerte P.
    Basic Res Cardiol; 2009 Jul 28; 104(4):435-48. PubMed ID: 19148693
    [Abstract] [Full Text] [Related]

  • 11. Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension.
    Umar S, Hessel M, Steendijk P, Bax W, Schutte C, Schalij M, van der Wall E, Atsma D, van der Laarse A.
    Pathol Res Pract; 2007 Jul 28; 203(12):863-72. PubMed ID: 17913382
    [Abstract] [Full Text] [Related]

  • 12. Pathological changes and myocardial remodelling related to the mode of shunting following surgical palliation for hypoplastic left heart syndrome.
    Padalino MA, Castellani C, Toffoli S, Della Barbera M, Milanesi O, Thiene G, Stellin G, Angelini A.
    Cardiol Young; 2008 Aug 28; 18(4):415-22. PubMed ID: 18588727
    [Abstract] [Full Text] [Related]

  • 13. Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure.
    Kato T, Niizuma S, Inuzuka Y, Kawashima T, Okuda J, Tamaki Y, Iwanaga Y, Narazaki M, Matsuda T, Soga T, Kita T, Kimura T, Shioi T.
    Circ Heart Fail; 2010 May 28; 3(3):420-30. PubMed ID: 20176713
    [Abstract] [Full Text] [Related]

  • 14. The effects of basic fibroblast growth factor in an animal model of acute mechanically induced right ventricular hypertrophy.
    Vida VL, Dedja A, Faggin E, Speggiorin S, Padalino MA, Boccuzzo G, Pauletto P, Angelini A, Milanesi O, Thiene G, Stellin G.
    Cardiol Young; 2012 Aug 28; 22(4):436-42. PubMed ID: 22281050
    [Abstract] [Full Text] [Related]

  • 15. Suppression of right ventricular hypertrophy after extensive pulmonary resection in rats by granulocyte colony-stimulating factor.
    Matsumoto S, Iwata H, Shirahashi K, Saio M, Umeda Y, Marui T, Ishida N, Kimura M, Sugimoto T, Manabe H, Takemura H.
    J Surg Res; 2010 Aug 28; 162(2):153-9. PubMed ID: 19457496
    [Abstract] [Full Text] [Related]

  • 16. Cardiotin localization in mitochondria of cardiomyocytes in vivo and in vitro and its down-regulation during dedifferentiation.
    Driesen RB, Verheyen FK, Schaart G, de Mazière A, Viebahn C, Prinzen FW, Lenders MH, Debie W, Totzeck A, Borgers M, Ramaekers FC.
    Cardiovasc Pathol; 2009 Aug 28; 18(1):19-27. PubMed ID: 18402829
    [Abstract] [Full Text] [Related]

  • 17. Expression of mitochondrial fusion-fission proteins during post-infarction remodeling: the effect of NHE-1 inhibition.
    Javadov S, Rajapurohitam V, Kilić A, Hunter JC, Zeidan A, Said Faruq N, Escobales N, Karmazyn M.
    Basic Res Cardiol; 2011 Jan 28; 106(1):99-109. PubMed ID: 20886221
    [Abstract] [Full Text] [Related]

  • 18. Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway.
    Rana OR, Saygili E, Meyer C, Gemein C, Krüttgen A, Andrzejewski MG, Ludwig A, Schotten U, Schwinger RH, Weber C, Weis J, Mischke K, Rassaf T, Kelm M, Schauerte P.
    J Mol Cell Cardiol; 2009 Apr 28; 46(4):568-78. PubMed ID: 19150448
    [Abstract] [Full Text] [Related]

  • 19. Enhanced expression and activity of xanthine oxidoreductase in the failing heart.
    de Jong JW, Schoemaker RG, de Jonge R, Bernocchi P, Keijzer E, Harrison R, Sharma HS, Ceconi C.
    J Mol Cell Cardiol; 2000 Nov 28; 32(11):2083-9. PubMed ID: 11040111
    [Abstract] [Full Text] [Related]

  • 20. Greater hypertrophy in right than left ventricles is associated with pulmonary vasculopathy in sinoaortic-denervated Wistar-Kyoto rats.
    Miao CY, Cai GJ, Tao X, Xie HH, Su DF.
    Clin Exp Pharmacol Physiol; 2004 Jul 28; 31(7):450-5. PubMed ID: 15236633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.